Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Hims & Hers Zepbound Offering Won’t Bring Needed Sales Boom, Analysts Say
In This Article:
Investors worry patients won’t make that price leap and that Hims, which has built its business on affordable healthcare, will struggle to meet its revenue goal.
Terms and Privacy Policy